Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2022 Results

TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the

Related Keywords

United States ,Canada ,Toronto ,Ontario ,Canadian ,Isa Odidi ,Company Oxycodone ,Company Contact ,Nasdaq ,Tris Pharma Inc ,Intellipharmaceutics International Inc ,Health Canada ,Party Transactions ,Intellipharmaceutics International ,Dexmethylphenidate Extended Release Capsules ,Par Pharmaceutical ,Tris Pharma ,Point Of Divergence Drug Delivery System ,Securities Act ,Management Discussion ,Intellipharmaceutics ,Nternational ,Nnounces ,First ,Quarter ,022 ,Results ,